Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elidel in mild-to-moderate chronic hand dermatitis
NCT00226707Phase 3Completed
- Sponsor
- Novartis
- Start
- Jul 2004
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of pimecrolimus in chronic hand dermatitis (CHE), sponsored by Novartis. Started Jul 2004; status: completed.
02
Drugs
pimecrolimus
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on NCT00226707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00226707.